Vasodilator efficiency of endogenous prostanoids, Ca 2+-activated K + channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension

Hypertension Research

Volumn 34, Issue 8, 2011, Pages 968-975

  Behuliak, Michal ^a,b   Pintérová, Mária ^a   Kune, Jaroslav ^a   Zicha, Josef ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b Bratislava   (Slovakia)

Author keywords

Ca 2+ activated K + channels; indomethacin; nitric oxide dependent vasodilatation; prostacyclin; tetraethylammonium

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CAPTOPRIL; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOLONIUM TARTRATE; PROSTANOID; TETRYLAMMONIUM;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CYCLOOXYGENASE INHIBITORS; HYPERTENSION; INDOMETHACIN; NITRIC OXIDE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROSTAGLANDINS; RATS; RATS, INBRED DAHL; RATS, INBRED SHR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 79961178881     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.82     Document Type: Article

References (40)

1. Zicha J, Dobesová Z, Kunes J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 2001; 19: 247-254. (Pubitemid 32116275)
2. Pechán ová O, Dobesová Z, Cejka J, Kunes J, Zicha J. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens 2004; 22: 167-173. (Pubitemid 38293544)
3. Kunes J, Dobesová Z, Zicha J. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci (Lond) 2002; 102: 269-277. (Pubitemid 34214389)
4. Paulis L, Lísková S, Pintérová M, Dobesová Z, Kunes J, Zicha J. Nifedipinesensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol (Oxf) 2007; 191: 255-266. (Pubitemid 350077444)
5. Kunes J, Hojná S, Kadlecová M, Dobesová Z, Rauchová H, Vokurková M, Loukotová J, Pechán ová O, Zicha J. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol Res 2004; 53(Suppl 1): S23-S34. (Pubitemid 38612851)
6. Dobesová Z, Kunes J, Zicha J. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies. J Hypertens 2002; 20: 945-955. (Pubitemid 34913676)
7. Zicha J, Dobesová Z, Kunes J. Adaptive role of nitric oxide (NO) in hypertension: relative but not absolute deficiency. Adapt Med 2009; 1: 112.
8. Limas C, Goldman P, Limas CJ, Iwai J. Effect of salt on prostaglandin metabolism in hypertension-prone and-resistant Dahl rats. Hypertension 1981; 3: 219-224. (Pubitemid 11118000)
9. Uehara Y, Tobian L, Iwai J, Ishii M, Sugimoto T. Alterations of vascular prostacyclin and thromboxane A2 in Dahl genetical strain susceptible to salt-induced hypertension. Prostaglandins 1987; 33: 727-738. (Pubitemid 17120167)
10. Uehara Y, Ishimitsu T, Ishii M, Sugimoto T. Prostacyclin synthase and phospholipases in the vascular wall of experimental hypertensive rats. Prostaglandins 1987; 34: 423-432.
11. Osanai T, Matsumura H, Kikuchi T, Minami O, Yokono Y, Akiba R, Eidou H, Konta A, Kanazawa T, Onodera K, Metoki H, Oike Y. Changes in vascular wall production of prostacyclin and thromboxane A2 in spontaneously hypertensive rats during maturation and the concomitant development of hypertension. Jpn Circ J 1990; 54: 507-514. (Pubitemid 20341255)
12. Ishimitsu T, Uehara Y, Ishii M, Ikeda T, Matsuoka H, Sugimoto T. Alterations of the cardiovascular and renal prostaglandins and thromboxanes system in prehypertensive spontaneously hypertensive rats. Jpn Circ J 1989; 53: 307-312. (Pubitemid 19186936)
13. Inglés AC, Ruiz FJ, Salom MG, Quesada T, Carbonell LF. Role of nitric oxide and prostaglandins in the regulation of blood pressure in conscious rats. Can J Physiol Pharmacol 1995; 73: 693-698.
14. Ruiz FJ, Inglés AC, Quesada T, Salom MG, Carbonell LF. Indomethacin does not modify the role of nitric oxide on blood pressure regulation of SHR. Gen Pharmacol 1994; 25: 103-106. (Pubitemid 24055418)
15. Imaizumi T, Takeshita A, Ashihara T, Nakamura M. Salt loading augments vascular responses to indomethacin in stroke-prone SHR. Am J Physiol 1982; 243: H360-H364. (Pubitemid 12000003)
16. Imaizumi T, Takeshita A, Ashihara T, Nakamura M. Endogenous prostaglandins do not modulate the hindquarters vascular responses to adrenergic stimulation in rats. Prostaglandins Leukot Med 1983; 10: 65-72. (Pubitemid 13196447)
17. Chrysant SG, Townsend SM, Morgan PR. The effects of salt and meclofenamate administration on the hypertension of spontaneously hypertensive rats. Clin Exp Hypertens 1978-1979; 1: 381-391.
18. Chrysant SG, Baxter PR, Almonette RL. Systemic and renal hemodynamic effects of captopril and meclofenamate in salt-treated SHR. Curr Ther Res 1983; 34: 857-868. (Pubitemid 14214546)
19. Nakanishi K, Chinen A, Saito Y, Hamada K, Hara N, Nagai Y. Nitric oxide buffers renal medullary vasoconstriction induced by prostaglandins synthesis blockade. Hypertens Res 2001; 24: 699-704. (Pubitemid 33133784)
20. Cox RH. Changes in the expression and function of arterial potassium channels during hypertension. Vasc Pharmacol 2002; 38: 13-23. (Pubitemid 36398286)
21. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology 2006; 21: 69-79. (Pubitemid 43752519)
22. Jones AW. Altered ion transport in vascular smooth muscle from spontaneously hypertensive rats. Influences of aldosterone, norepinephrine, and angiotensin. Circ Res 1973; 33: 563-572.
23. Jones AW, Hart RG. Altered ion transport in aortic smooth muscle during deoxycorticosterone acetate hypertension in the rat. Circ Res 1975; 37: 333-341.
24. Furspan PB, Bohr DF. Lymphocyte abnormalities in three types of hypertension in the rat. Hypertension 1985; 7: 860-866. (Pubitemid 16147465)
25. Furspan PB, Bohr DF. Calcium sensitivity of Ca2+-activated K+ channels in spontaneously hypertensive stroke-prone rats. Hypertension 1990; 15(Suppl I): 97-101.
26. Minami N, Imai Y, Hashimoto J, Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci (Lond) 1995; 89: 177-182.
27. Jones SB, Liu Y, Jones AW. Altered aortic production of 6-keto-prostaglandin F1a from aldosterone-salt hypertensive rats. J Vasc Res 1992; 29: 256-263.
28. Vane JR, Botting RM. Secretory functions of the vascular endothelium. J Physiol Pharmacol 1992; 43: 195-207.
29. Pintérová M, Lísková S, Dobesová Z, Behuliak M, Kunes J, Zicha J. Impaired control of L-type voltage-dependent calcium channels in experimental hypertension. Physiol Res 2009; 58(Suppl 2): S43-S54.
30. Pintérová M, Karen P, Kunes J, Zicha J. Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertussis toxin. J Hypertens 2010; 28: 969-978.
31. Jones AW. Ionic dysfunction and hypertension. Adv Microcirc 1982; 11: 134-159.
32. Furspan PB, Bohr DF. Cell membrane permeability in hypertension. Clin Physiol Biochem 1988; 6: 122-129.
33. Bohr DF. Cell membrane in hypertension. News Physiol Sci 1989; 4: 85-88.
34. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation 2002; 9: 243-257. (Pubitemid 135685861)
35. Lísková S, Petrová M, Karen P, Kunes J, Zicha J. Influence of calcium-dependent potassium channel blockade and nitric oxide inhibition on norepinephrine-induced contractions in two forms of genetic hypertension. J Am Soc Hypertens 2010; 4: 128-134.
36. Grimm PR, Irsik DL, Settles DC, Holtzclaw JD, Sansom SC. Hypertension of Kcnmb1-/-is linked to deficient K secretion and aldosteronism. Proc Natl Acad Sci USA 2009; 106: 11800-11805.
37. Brenner R, Peréz GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW. Vasoregulation by the b1 subunit of the calcium-activated potassium channel. Nature 2000; 407: 870-876.
38. Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, Abdullah U, Krippeit-Drews P, Feil R, Hofmann F, Knaus HG, Kenyon C, Shipston MJ, Storm JF, Neuhuber W, Korth M, Schubert R, Gollasch M, Ruth P. Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 2005; 112: 60-68. (Pubitemid 40962570)
39. Plü ger S, Faulhaber J, Fü rstenau M, Löhn M, Waldschü tz R, Gollasch M, Haller H, Luft FC, Ehmke H, Pongs O. Mice with disrupted BK channel b1 subunit gene feature abnormal Ca2+ spark/STOC coupling and elevated blood pressure. Circ Res 2000; 87: E53-E60.
40. Nelson MT, Standen NB, Brayden JE, Worley JF. Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature 1988; 336: 382-385.